CA2536069C - Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire - Google Patents

Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire Download PDF

Info

Publication number
CA2536069C
CA2536069C CA002536069A CA2536069A CA2536069C CA 2536069 C CA2536069 C CA 2536069C CA 002536069 A CA002536069 A CA 002536069A CA 2536069 A CA2536069 A CA 2536069A CA 2536069 C CA2536069 C CA 2536069C
Authority
CA
Canada
Prior art keywords
green
light
porphyrin
choroidal
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002536069A
Other languages
English (en)
Other versions
CA2536069A1 (fr
Inventor
Joan W. Miller
Evangelos S. Gragoudas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Eye and Ear
Original Assignee
Massachusetts Eye and Ear Infirmary
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Eye and Ear Infirmary filed Critical Massachusetts Eye and Ear Infirmary
Publication of CA2536069A1 publication Critical patent/CA2536069A1/fr
Application granted granted Critical
Publication of CA2536069C publication Critical patent/CA2536069C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002536069A 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire Expired - Lifetime CA2536069C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1994/002639 WO1995024930A1 (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire
CA2185644A CA2185644C (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2185644A Division CA2185644C (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire

Publications (2)

Publication Number Publication Date
CA2536069A1 CA2536069A1 (fr) 1995-09-21
CA2536069C true CA2536069C (fr) 2008-06-03

Family

ID=22242340

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2185644A Expired - Lifetime CA2185644C (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire
CA002536069A Expired - Lifetime CA2536069C (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2185644A Expired - Lifetime CA2185644C (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire

Country Status (3)

Country Link
AU (1) AU6813694A (fr)
CA (2) CA2185644C (fr)
WO (1) WO1995024930A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770592A (en) 1991-11-22 1998-06-23 Alcon Laboratories, Inc. Prevention and treatment of ocular neovascularization using angiostatic steroids
JP3845469B2 (ja) 1996-02-21 2006-11-15 明治製菓株式会社 眼底の新生血管の閉塞に用いる投与剤
US5756541A (en) * 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
NZ331977A (en) * 1996-03-26 2000-07-28 Pharmacyclics Inc Texaphyrin in photodynamic therapy of pigment-related lesions
US6043237A (en) * 1996-12-10 2000-03-28 Qlt Phototherapeutics, Inc. Use of photodynamic therapy for prevention of secondary cataracts
US6270749B1 (en) 1996-12-11 2001-08-07 Pharmacyclics, Inc. Use of Texaphyrin in ocular diagnosis and therapy
CN1265039A (zh) * 1996-12-11 2000-08-30 环状药物公司 泰克萨菲瑞在制备用于诊断和治疗眼部疾病的药物中的应用
US6022526A (en) * 1997-07-30 2000-02-08 Pharmacyclics, Inc. Use of texaphyrins in detection of melanin and melanin metabolites diagnostic of melanotic melanoma
US6117862A (en) * 1998-10-09 2000-09-12 Qlt, Inc. Model and method for angiogenesis inhibition
IL126953A0 (en) 1998-11-08 1999-09-22 Yeda Res & Dev Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives
US6351663B1 (en) 1999-09-10 2002-02-26 Akorn, Inc. Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
US6944493B2 (en) 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
AU7106400A (en) * 1999-09-10 2001-04-10 Akorn, Inc. Fluorescent dye angiography and dye-enhanced photocoagulation
US6443976B1 (en) 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
US20020049247A1 (en) * 2000-01-12 2002-04-25 Chen James C. Novel treatment for eye disease
WO2001058240A2 (fr) * 2000-02-10 2001-08-16 Massachusetts Eye And Ear Infirmary Methodes et compositions destinees au traitement d'affections oculaires
AU2006203034B2 (en) * 2000-02-10 2006-09-07 Massachusetts Eye And Ear Infirmary Methods and compositions for treating conditions of the eye
CA2437557C (fr) 2001-02-06 2012-07-24 Qlt Inc. Therapie photodynamique a debit de fluence reduit permettant de traiter la neovascularisation choroidienne due a l'amd
US7753943B2 (en) 2001-02-06 2010-07-13 Qlt Inc. Reduced fluence rate PDT
JP2005511576A (ja) * 2001-11-09 2005-04-28 アイテック・ファーマシューティカルズ 眼球血管新生病を治療する方法
US6723750B2 (en) 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
US7288106B2 (en) 2002-10-03 2007-10-30 Light Sciences Oncology, Inc. System and method for excitation of photoreactive compounds in eye tissue

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5214036A (en) * 1990-03-08 1993-05-25 University Of British Columbia Benzoporphyrin derivatives for photodynamic therapy

Also Published As

Publication number Publication date
CA2185644C (fr) 2011-04-12
WO1995024930A1 (fr) 1995-09-21
CA2185644A1 (fr) 1995-09-21
AU6813694A (en) 1995-10-03
CA2536069A1 (fr) 1995-09-21

Similar Documents

Publication Publication Date Title
US5707986A (en) Angiographic method using green porphyrins in primate eyes
US6225303B1 (en) Use of green porphyrins to treat neovasculature in the eye
CA2536069C (fr) Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire
EP0894009B1 (fr) Vision amelioree par therapie photodynamique de l'oeil
EP0799055B1 (fr) Visualisation ou traitement selectif et non invasif du systeme vasculaire
Peyman et al. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2)
JP2003519670A (ja) 眼疾患の新規処置
US6524330B1 (en) Method of ocular treatment
Moshfeghi et al. Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies
Moshfeghi et al. Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys
Levy et al. Use Of Green Porphyrinsto Treat Neovasculature In The Eyes
AU705100C (en) Improved vision through photodynamic therapy of the eye
JPWO2001060360A1 (ja) 眼底組織中の新生血管を選択的に閉塞する光線力学療法

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20140314